Optimi Health Corp. is a Canadian-based pharmaceutical and life sciences company specializing in the research, cultivation, and manufacturing of controlled substances and functional mushrooms. Headquartered in Vancouver, the company operates a sophisticated, large-scale production facility in Princeton, British Columbia, which is Health Canada-licensed and GMP-compliant. Optimi Health is positioned as a vertically integrated provider in the emerging psychedelic therapy industry. The company focuses on producing high-quality, standardized psilocybin and MDMA for use in clinical trials and authorized therapeutic applications. Their facility is designed to meet the rigorous standards required for pharmaceutical supply chains, aiming to become a primary global supplier as regulatory frameworks for psychedelic medicine evolve. In addition to its controlled substances division, Optimi Health produces a range of functional mushroom supplements—including Lion's Mane, Reishi, and Cordyceps—targeted at the health and wellness consumer market. By combining advanced indoor growing technology with scientific research, the company seeks to validate the therapeutic benefits of fungi and provide safe, scalable solutions for mental health and physical performance. The company's strategy involves securing international export permits and establishing strategic partnerships with research institutions and healthcare providers worldwide.
Book value of equity per share effectively indicates a firm's net asset value (total assets - total liabilities) on a per-share basis. References: Below 1: the company is trading below its equity. Equal to 1: the company is trading at the exact value of its equity. Above 1: The company is trading above its equity.
Shows how much the market values every dollar of the company's sales.
Shows how much the market values every dollar of the company's EBITDA.
The price-to-cash flow (P/CF) ratio is a stock valuation indicator or multiple that measures the value of a stock's price relative to its operating cash flow per share. The ratio uses operating cash flow (OCF), which adds back non-cash expenses such as depreciation and amortization to net income. P/CF is especially useful for valuing stocks that have positive cash flow but are not profitable because of large non-cash charges.
The price-to-free cash flow (P/FCF) ratio is a stock valuation indicator or multiple that measures the value of a stock's price relative to its free cash flow per share. This metric is very similar to the valuation metric of price to cash flow but is considered a more exact measure because it uses free cash flow, which subtracts capital expenditures (CAPEX) from a company's total operating cash flow, thereby reflecting the actual cash flow available to fund non-asset-related growth.
The price-to-earnings ratio is the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS) and is used by investors and analysts to determine the relative value of a company's shares in an apples-to-apples comparison.
Book value per share (BVPS) takes the ratio of a firm's common equity divided by its number of shares outstanding.
Earnings per share (EPS) is calculated as a company's profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company's profitability. EPS indicates how much money a company makes for each share of its stock and is a widely used metric for estimating corporate value.
...and much more!